|Mr. Dennis P. Calvert||Chairman, Pres & CEO||319.93k||N/A||1963|
|Mr. Charles K. Dargan II, C.F.A.||Chief Financial Officer||N/A||N/A||1955|
|Mr. Joseph L. Provenzano||VP of Operations, Corp. Sec. & Director||186.34k||N/A||1969|
|Mr. Kenneth Reay Code||Chief Science Officer & Director||301.2k||N/A||1947|
|Mr. Mitch Noto||Director of Corp. Devel.||N/A||N/A||N/A|
BioLargo, Inc. operates as a technology developer and environmental engineering company in the United States. The company operates through Odor-No-More, BLEST, BioLargo Water, and Clyra Medical segments. Its platform technology, Advanced Oxidation System (AOS) is a water treatment system for decontamination and disinfection. The company offers odor and volatile organic compound control products, and AOS water treatment technologies, as well as professional engineering and consulting services. In addition, it offers wound care products for traumatic injury, diabetic ulcers, and chronic hard-to-heal wounds. The company provides its products under the CupriDyne Clean, Nature's Best Science, and Deodorall brand names. BioLargo, Inc. is based in Westminster, California.
BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.